Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: A randomised, placebo-controlled, double-blind trial

A. Straumann, S. Conus, P. Grzonka, H. Kita, G. Kephart, C. Bussmann, C. Beglinger, D. A. Smith, J. Patel, M. Byrne, H. U. Simon

Research output: Contribution to journal › Article › peer-review

373 Scopus citations

Fingerprint

Dive into the research topics of 'Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: A randomised, placebo-controlled, double-blind trial'. Together they form a unique fingerprint.

Medicine & Life Sciences